Healthcare provider profile · identity verified

Thuyet Van Tran, M.D.

Internal Medicine · DAMASCUS, OR · NPI 1063626497

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	812	245
Amlodipine Besylate	Amlodipine Besylate	531	153
Lisinopril	Lisinopril	488	144
Twinrix	Hepatitis A And B Vaccine/Pf	381	218
Metformin Hcl	Metformin Hcl	358	108
Losartan Potassium	Losartan Potassium	329	102
Albuterol Sulfate Hfa	Albuterol Sulfate	316	69
Alendronate Sodium	Alendronate Sodium	305	78
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	287	222
Lidocaine	Lidocaine	281	65
Omeprazole	Omeprazole	248	68
Gabapentin	Gabapentin	204	50
Shingrix	Varicella-Zoster Ge/As01b/Pf	162	131
Diclofenac Sodium	Diclofenac Sodium	151	79
Atenolol	Atenolol	145	42
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	139	38
Tamsulosin Hcl	Tamsulosin Hcl	139	48
Arexvy	Rsvpref3 Antigen/As01e/Pf	138	138
Levothyroxine Sodium	Levothyroxine Sodium	129	33
Trazodone Hcl	Trazodone Hcl	128	38
Glipizide	Glipizide	127	39
Fluticasone Propionate	Fluticasone Propionate	118	30
Prednisone	Prednisone	116	49
Rosuvastatin Calcium	Rosuvastatin Calcium	116	42
Metoprolol Succinate	Metoprolol Succinate	107	29
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	105	52
Ezetimibe	Ezetimibe	105	28
Hydrochlorothiazide	Hydrochlorothiazide	102	33
Lovastatin	Lovastatin	95	33
Triamcinolone Acetonide	Triamcinolone Acetonide	93	33
Furosemide	Furosemide	90	27
Allopurinol	Allopurinol	89	27
Metoprolol Tartrate	Metoprolol Tartrate	88	29
Simvastatin	Simvastatin	85	22
Sertraline Hcl	Sertraline Hcl	84	18
Pioglitazone Hcl	Pioglitazone Hcl	83	25
Eliquis	Apixaban	75	15
Pravastatin Sodium	Pravastatin Sodium	73	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	21
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	71	31
Clonazepam	Clonazepam	66	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	21
Amoxicillin	Amoxicillin	62	41
Baclofen	Baclofen	62	26
Hydralazine Hcl	Hydralazine Hcl	56	20
Ibuprofen	Ibuprofen	55	20
Carvedilol	Carvedilol	54	18
Donepezil Hcl	Donepezil Hcl	53	20
Hydroxyzine Hcl	Hydroxyzine Hcl	51	17
Clopidogrel	Clopidogrel Bisulfate	50	16
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	48	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	13
Meclizine Hcl	Meclizine Hcl	48	26
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Havrix	Hepatitis A Virus Vaccine/Pf	46	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Azithromycin	Azithromycin	44	24
Dutasteride	Dutasteride	43	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Loperamide	Loperamide Hcl	42	20
Montelukast Sodium	Montelukast Sodium	40	12
Azelastine Hcl	Azelastine Hcl	39	13
Glipizide Er	Glipizide	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Varenicline Tartrate	Varenicline Tartrate	38	13
Nystatin	Nystatin	37	suppressed
Nifedipine Er	Nifedipine	36	suppressed
Albuterol Sulfate	Albuterol Sulfate	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	12
Ondansetron Hcl	Ondansetron Hcl	34	suppressed
Clobetasol Propionate	Clobetasol Propionate	33	suppressed
Cephalexin	Cephalexin	32	25
Finasteride	Finasteride	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	21
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Olanzapine	Olanzapine	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Amantadine	Amantadine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	12
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Famotidine	Famotidine	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Risperdal Consta	Risperidone Microspheres	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Ibu	Ibuprofen	24	14
Buspirone Hcl	Buspirone Hcl	23	suppressed
Estradiol	Estradiol	23	suppressed
Megestrol Acetate	Megestrol Acetate	23	suppressed
Meloxicam	Meloxicam	23	13
Warfarin Sodium	Warfarin Sodium	23	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Compro	Prochlorperazine	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Naproxen	Naproxen	16	suppressed
Ozempic	Semaglutide	16	suppressed
Risperidone	Risperidone	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Restasis	Cyclosporine	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error